391 related articles for article (PubMed ID: 7511682)
1. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
Burrows SR; Khanna R; Burrows JM; Moss DJ
J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.
Burrows SR; Silins SL; Cross SM; Peh CA; Rischmueller M; Burrows JM; Elliott SL; McCluskey J
Eur J Immunol; 1997 Jan; 27(1):178-82. PubMed ID: 9022015
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
6. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
[TBL] [Abstract][Full Text] [Related]
7. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
[TBL] [Abstract][Full Text] [Related]
8. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
9. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
[TBL] [Abstract][Full Text] [Related]
10. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
[TBL] [Abstract][Full Text] [Related]
11. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.
Kerr BM; Kienzle N; Burrows JM; Cross S; Silins SL; Buck M; Benson EM; Coupar B; Moss DJ; Sculley TB
J Virol; 1996 Dec; 70(12):8858-64. PubMed ID: 8971014
[TBL] [Abstract][Full Text] [Related]
12. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
Bogedain C; Wolf H; Modrow S; Stuber G; Jilg W
J Virol; 1995 Aug; 69(8):4872-9. PubMed ID: 7609055
[TBL] [Abstract][Full Text] [Related]
13. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
[TBL] [Abstract][Full Text] [Related]
14. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
Khanna R; Burrows SR; Nicholls J; Poulsen LM
Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
[TBL] [Abstract][Full Text] [Related]
15. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
Mifsud NA; Nguyen TH; Tait BD; Kotsimbos TC
Transplantation; 2010 Dec; 90(12):1439-49. PubMed ID: 21042237
[TBL] [Abstract][Full Text] [Related]
17. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
Lee SP; Thomas WA; Murray RJ; Khanim F; Kaur S; Young LS; Rowe M; Kurilla M; Rickinson AB
J Virol; 1993 Dec; 67(12):7428-35. PubMed ID: 7693972
[TBL] [Abstract][Full Text] [Related]
18. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
Lee SP; Morgan S; Skinner J; Thomas WA; Jones SR; Sutton J; Khanna R; Whittle HC; Rickinson AB
Eur J Immunol; 1995 Jan; 25(1):102-10. PubMed ID: 7531142
[TBL] [Abstract][Full Text] [Related]
20. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
